Combination of vaccination and inhibition of mhc class i restricted antigen presentation
AssigneeCureVac AG
InventorsChristina Lorenz, Mariola Fotin-Mleczek, Karl-Josef Kallen
Life of this patent
Estimating the term…
Loading patent…
AssigneeCureVac AG
InventorsChristina Lorenz, Mariola Fotin-Mleczek, Karl-Josef Kallen
Estimating the term…
The present invention relates to a vaccine/inhibitor combination comprising as a vaccine at least one antigen and as an inhibitor at least one inhibitor of the major histocompatibility complex (MHC) class I restricted antigen presentation. The present invention furthermore relates to a method of vaccination of a mammal using the inventive vaccine/inhibitor combination. The present invention also provides kit of parts comprising the inventive vaccine/inhibitor combination, preferably in different parts of the kit, e.g. for prior, concurrent or subsequent administration of the different parts. Additionally the invention relates to a pharmaceutical composition comprising the inventive vaccine/inhibitor combination to further improve the immune response against tumour cells and infected cells having lost the capability of MHC class I restricted antigen presentation.
Vaccine/inhibitor combination comprising as a vaccine at least one antigen and as an inhibitor at least one inhibitor of MHC class I restricted antigen presentation.
(canceled)
Dependencies are inferred from the claim text.